NeuroVision Imaging, LLC Eye Test Part of Major Alzheimer’s Trial

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SACRAMENTO, Calif.--(BUSINESS WIRE)--Researchers in Perth are trialling a NeuroVision eye test as a screening tool for Alzheimer’s disease. Professor Yogi Kanagasingam, a world leader in ocular imaging in CSIRO’s Preventative Health Flagship said, “If this test works, then one day screening for Alzheimer’s disease may be as simple as getting your eyes checked”. The trial is a collaboration between CSIRO, Edith Cowan University, McCusker Alzheimer’s Research Foundation and California-based NeuroVision Imaging. Professor Ralph Martins, a pioneer in Alzheimer’s disease research, is a co-lead on the research which is being conducted at the McCusker Alzheimer’s Research Foundation in Perth, Western Australia. The project is part of the Australian Imaging and Biomarkers Lifestyle Study of Aging (AIBL), which has 1000 volunteers who are making a valuable contribution to Alzheimer’s research.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC